User Posts: admin3
0
Androgen Deprivation Therapy for Prostate Cancer
0

Transcript:What is androgen deprivation therapy?Alicia Morgans, M.D., MPH: Androgen deprivation therapy, sometimes called ADT or hormonal therapy, is a way ...

0
Cancer And The Dance With Death
0

A scene that always grips me depicts Death asking his mortal romantic interest to gaze into his eyes so that she might see his truest, immortal self. A look ...

0
Now Nurses, Two Pediatric Cancer Survivors Help a New Generation of Patients
0

Both Laura Shinn and Jenna Cavalero began their histories with cancer as pediatric patients at Children’s Hospital of New Orleans, nearly 25 years apart. ...

0
TikTok Users Spread Misinformation About Gynecologic Cancers
0

Some TikTok videos included misinformation about gynecologic cancer, researchers found. Users on TikTok are spreading misleading or false information about ...

0
Metastatic Hormone-Sensitive Prostate Cancer Treatment Options
0

Transcript:For patients with metastatic hormone-sensitive prostate cancer, what are the treatment options?Alicia Morgans, M.D., MPH: Metastatic ...

0
Chemo Shortage Improved But Remains an ‘Ongoing Crisis’
0

A recent survey of National Comprehensive Cancer Network (NCCN)-designated cancer centers revealed that 86% of surveyed institutions are experiencing a ...

0
Sexual Activity May Reduce Long-Term Side Effects After Cervical Cancer
0

Engaging in sexual activity or vaginal dilation may lower the risk of developing long-term side effects for patients with cervical cancer, according to ...

0
Selecting Appropriate Treatments for Patients With Advanced RCC
0

Expert perspectives on the decision-making process for selecting frontline systemic therapy for patients with advanced renal cell carcinoma.

0
Exercise Can Help Empower Patients With Cancer
0

Research shows that exercise can reduce the rate of cancer recurrence, from 20% to 60% less, according to Jen Miramontes, founder of Cancer Champions, a ...

0
FDA Approves Braftovi and Mektovi for Some Patients with Metastatic NSCLC
0

The Food and Drug Administration (FDA) has approved Braftovi (encorafenib) with Mektovi (binimetinib) for the treatment of adult patients with metastatic ...

User Deals: admin3
Browsing All Comments By: admin3
CML Alliance
Logo
Enable registration in settings - general
Compare items
  • Total (0)
Compare
0
Shopping cart